Rocatinlimab exhibits positive results in phase 3 study for atopic dermatitis
The phase 3 ROCKET HORIZON trial showed promising results for rocatinlimab, an…
Pfizer pulls sickle cell treatment Oxbryta off global markets
Pfizer is globally removing the sickle cell disease treatment pill, Oxbryta, due…
Labour government rolls out surgical HIT list model to areas of economic inactivity
The government has announced that hospitals in areas with high rates of…
Women with premature ovarian insufficiency found to be at greater risk of severe autoimmune diseases
A study led by Dr. Susanna Savukoski from Finland found that women…
New AI tool revolutionizes drug discovery for rare diseases
A new artificial intelligence tool called TxGNN has been developed to identify…
Which Biopsy for Elevated PSA?
A new study compared MRI-targeted biopsy to systematic biopsy for prostate cancer…
Best Medicine Balls To Boost Strength And Power
Medicine balls are versatile tools for improving overall fitness, strength, coordination, and…
Considering Covering GLP-1s? Here’s What You Need to Know
Employer healthcare costs are projected to rise by 9% next year, primarily…
Letter: Cariban controversy
Dr. Naomi Smith, a GP and member of Hyperemesis Ireland, thanks the…
Understanding ADHD: A Comprehensive Guide
ADHD is a neurodevelopmental disorder that can persist into adulthood, affecting various…